Search results
JudyAnn Bigby
GBH News· 6 days agoSecretary of Health and Human Services, Dr. JudyAnn Bigby, oversees 17 state agencies and serves in the Cabinet of Governor Deval Patrick. One of...
New York needs comprehensive federal reform for the 340B drug pricing program
Lohud | The Journal News via Yahoo News· 3 days agoAdditionally, more than 40% of New Yorkers live with a chronic disease, and six out of every 10 deaths in state are caused by chronic disease. Community and business leaders should be at the ...
Shockwave Medical Reports First Quarter 2024 Financial Results
Morningstar· 2 days agoSANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment ...
Henk Goorhuis: Rural health care in Maine: Essential and at risk
The Lewiston Sun Journal· 7 days agoSmall rural hospitals, clinics and health care providers face steep challenges in U.S. health care, including staffing shortages and financial strain largely caused by complicated payment systems ...
Johnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024
Char-Koosta News· 6 days agoCompany to present, across eight data presentations, new real-world research on the economic value...
Bloomberg Tax & Accounting Recognizes 2023 Federal Authors of The Year
The Jacksonville Daily News· 2 days agoBloomberg Tax & Accounting announced today its 2023 Author Awards for Federal Tax, which were presented in Washington, D.C. Alden Bianchi of McDermott Will & Emery received the Leonard L. Silverstein ...
Bloomberg Tax & Accounting Recognizes 2023 Federal Authors of The Year
The Times and Democrat· 2 days agoBloomberg Tax & Accounting announced today its 2023 Author Awards for Federal Tax, which were presented in Washington, D.C. Alden Bianchi of McDermott Will & Emery received the Leonard L. Silverstein ...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
The Longview News-Journal· 6 days agoJohnson & Johnson announced today updated results from Cohort 2 of the Phase 2b SunRISe-1 study evaluating the efficacy and safety of investigational TAR-200 monotherapy in patients with BCG-unresponsive ...